Effectiveness of Thyme in the Management of Clinical Symptoms in Patients with Irritable Bowel Syndrome
NCT ID: NCT06609746
Last Updated: 2024-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
52 participants
INTERVENTIONAL
2024-10-21
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
1. Does consumption of thyme reduce the severity score of clinical symptoms in patients with irritable bowel syndrome?
2. Does consumption of thyme increase the quality of life score in patients with irritable bowel syndrome? Researchers will compare thyme supplementation with placebo to see if thyme supplement enhances the effects of a low FODAMP diet on clinical symptoms and quality of life in patients with irritable bowel syndrome.
Participants will:
1. Receive thyme supplement plus a low FODMAP diet or placebo with low FODMAP diet for 8 weeks.
2. Recorde 3 days (1weekend and 2 workday) dietary recalls at week 4 and week 8 to assess adherence to the low FODMP diet.
3. Visit the clinic at the beginning of the study and the end of the study for a check-up and score record
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Healthy Human Subjects
NCT02667184
The Effects of FODMAPs in Patients With Irritable Bowel Syndrome
NCT05182593
Evaluation of Treatment Effect of Low FODMAP Diet in Treatment of IBS Patients
NCT05144204
Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel Syndrome
NCT02026518
Tritordeum-based Foods for IBS Symptoms
NCT05307185
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thyme
Taking thyme extract capsules with a low FODMAP diet
Thyme extract
Three Gastrolit capsules daily with a low FODMAP diet for 8 weeks
placebo
Taking placebo capsules with a low FODMAP diet
Placebo
Placebo capsules daily with a low FODMAP diet for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thyme extract
Three Gastrolit capsules daily with a low FODMAP diet for 8 weeks
Placebo
Placebo capsules daily with a low FODMAP diet for 8 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with irritable bowel syndrome;
* Body Mass Index in the range of 18-25 kg/m2
Exclusion Criteria
* Medical history of chronic gastrointestinal and colorectal disease;
* Any major bowel surgery;
* Medical history of liver and kidney disorders;
* Regular use of laxative, anti-diarrhea and anti inflammatory medications.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shahid Beheshti University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samira Rastgoo
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IR.SBMU.RETECH.REC.1399.1034
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.